Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04268953 · ClinicalTrials.gov registry record · Phase 1
Study to Compare the Pharmacokinetics of Daily Administration of Tricaprilin on Ketone Body Production
A Phase 1 study, sponsored by Cerecin.
- Completed
- Registry status
- Phase 1
- Development phase
- 12
- Enrollment target
NCT04268953: Completed Phase 1 study, sponsored by Cerecin.
NCT04268953 is a Phase 1 study that has completed, run by Cerecin. The registered enrollment target is 12 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04268953, a Phase 1 study, has completed, sponsored by Cerecin.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 12 participants
- Enrollment target
Study Summary
This is a Phase I, single center, open label, multiple dose, pharmacokinetic (PK) study recruiting healthy older subjects.
Interventions
- DRUG Tricaprilin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2020-02-27 |
| Est. Completion | 2020-05-01 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04268953
The ClinicalTrials.gov registry entry for NCT04268953 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cerecin, which has 11 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Tricaprilin is the first listed.
NCT04268953 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04268953 about?
NCT04268953 is a clinical study titled "Study to Compare the Pharmacokinetics of Daily Administration of Tricaprilin on Ketone Body Production". This is a Phase I, single center, open label, multiple dose, pharmacokinetic (PK) study recruiting healthy older subjects.
What is the current status of trial NCT04268953?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 12 participants. The study started on 2020-02-27. Estimated completion is 2020-05-01.
What interventions are being tested in trial NCT04268953?
The interventions under investigation include: Tricaprilin (DRUG).
Who is sponsoring clinical trial NCT04268953?
This trial is sponsored by Cerecin, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.